DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Mepitiostane
Mepitiostane
E- 2/SY) Q
(200731) Hypromellose Phthalate (220824) Ibudilast
159 Misuse of Drugs (Controlled Drugs) Order 2001
Pharmaceutical Appendix to the Tariff Schedule 2
Section B Changed Classes/Guidelines Final
Pound. Mepitiostane Administered Orally Suppressed the Growth of Transplanted Estrogen-Dependent Mammary Tumor in Rats
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Detection of Mepitiostane in Doping Analysis
Method of Administering and Using VEGF Inhibitors for the Treatment of Human Cancer
Pros and Cons Controversy on Molecular Imaging and Dynamic
Recent Advances in the Analysis of Steroid Hormones and Related Drugs
Antitumor Effect of Two Oral Steroids, Mepitiostane and Fluoxymesterone, on a Pregnancy-Dependent Mouse Mammary Tumor (TPDMT-4)1
Supplement Ii to the Japanese Pharmacopoeia Seventeenth Edition
Customs Tariff - Schedule
Police Regulations Amendment (Poisons) Regulations 2016
Poisons and Drugs Amendment Act 2000
The Misuse of Drugs Regulations (Northern Ireland) 2002
Absorption, Gastrointestinal, 39-43 ABT-229, 244F, 245 Abzymes, 533
Top View
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
A10 Steroids
Poison Or Antibiotic? a Guide to "Class" Entries
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Manfred Donike Workshop 2020 Table of Contents
Liposomal Formulations for Enhanced Lymphatic Drug Delivery
Sulfated and Sulfur-Containing Steroids and Their Pharmacological Profile
Transdermal Device Containing
General Information
General Information
Mass Spectrometric Identification of Epitiostanol Metabolite: in Vitro
Customs Tariff - Schedule Xxi - 1
Medicines (Designated Pharmacist Prescribers) Regulations 2013
United States Patent (19) 11 Patent Number: 5,811,547 Nakamichi Et Al
(12) Patent Application Publication (10) Pub. No.: US 2002/0004065 A1 Kanios (43) Pub
Harmonized Tariff Schedule of the United States (2006) (Rev
ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
Sustained-Release Formulation Comprising A
(12) Patent Application Publication (10) Pub. No.: US 2003/0114430 A1 Macleod Et Al
(12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
(12) United States Patent (10) Patent No.: US 8,765,725 B2 Cavanagh Et Al
ICD-10-CM TABLE of DRUGS and CHEMICALS
Controlled Drugs List
The Korea Food and Drug Administration* Notification 2012-129
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
ICD-10-CM Table of Drugs 2019
(19) United States (12) Patent Application Publication (10) Pub
(12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr